Sage Journals: Discover world-class research

Open access

Research article

First published 2020

Efficacy of iron supplementation in patients with inflammatory bowel disease treated with anti-tumor necrosis factor-alpha agents

Su Young Kim, Sejin An, Dong Kyun Park [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2017

Anti-Angiogenic Effects of Anti–Tumor Necrosis Factor α Agents in the Treatment of Behçet Disease

Nicola Maruotti, Addolorata Corrado, Francesco Paolo Cantatore

Clinical Medicine Insights: Therapeutics

Retricted access

Research article

First published 2011-3

Spectrofluorimetric Determination of SN-38,a Promising New Anti-Tumor Agent,in the Presence and Absence of Organized Media

Maria Isabel Rodríguez-Cáceres, Diego Bohoyo Gil, Isabel Durán-Merás [...]

Applied Spectroscopy

Free access

Research article

First published 2006-02

Protective effect of saffron (Crocus sativus L.) aqueous extract against genetic damage induced by anti-tumor agents in mice

K Premkumar, C Thirunavukkarasu, S K Abraham [...]

Human & Experimental Toxicology

Retricted access

Research article

First published 2002-9

Are dietary fats anti-tumor agents?

HC Sax

Journal of Parenteral and Enteral Nutrition

Free access

Research article

First published 2012-9

Tumor Targeting Using Anti–Epidermal Growth Factor Receptor (ior egf/r3) Immunoconjugate with a Tetraaza Macrocyclic Agent (DO3A-EA)

Gauri Mishra, Puja Panwar, Anil K. Mishra

Molecular Imaging

Open access

Review article

First published 2017-3

Tumor rim cells: From resistance to vascular targeting agents to complete tumor ablation

Khaled Seidi, Rana Jahanban-Esfahlan, Nosratollah Zarghami

Tumor Biology

Retricted access

Research article

First published 2017-5

Renal Toxicity in Patients Treated with Anti-Pd-1 Targeted Agents for Solid Tumors

Roberto Iacovelli, Chiara Ciccarese, Emanuela Fantinel [...]

Journal of Onco-Nephrology

Free access

Research article

First published 2020-11

Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn’s disease

Iago Rodríguez-Lago, Javier Del Hoyo, Alexandre Pérez-Girbés [...]

United European Gastroenterology Journal

Open access

Review article

First published 2022-11

Research Progress with Luteolin as an Anti-Tumor Agent

Zhun Cai, Chenyang Mao, Yeqing Wang [...]

Natural Product Communications

Search results